Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Buy
2,413
+6
+0.2% +$693 ﹤0.01% 227
2025
Q4
$253K Sell
2,407
-3
-0.1% -$282 ﹤0.01% 232
2025
Q3
$202K Sell
2,410
-597
-20% -$49.2K ﹤0.01% 258
2025
Q2
$238K Sell
3,007
-876
-23% -$69.6K ﹤0.01% 225
2025
Q1
$349K Sell
3,883
-744
-16% -$69.5K 0.01% 182
2024
Q4
$460K Buy
4,627
+141
+3% +$14.5K 0.01% 167
2024
Q3
$509K Buy
4,486
+900
+25% +$107K 0.01% 157
2024
Q2
$444K Buy
3,586
+1,060
+42% +$137K 0.01% 154
2024
Q1
$333K Buy
+2,526
New +$311K 0.01% 157

Other funds holding MRK

PGIM Custom Harvest's MRK Position: Q1 2026 in Review

PGIM Custom Harvest increased its Merck (MRK) stake by 0.25% in Q1 2026, buying an estimated $693 and bringing the position to 2,413 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

PGIM Custom Harvest first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $509K in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PGIM Custom Harvest held 2,413 shares of Merck worth $290K as of Q1 2026.
  • PGIM Custom Harvest bought 6 Merck shares in Q1 2026, an estimated $693.
  • Merck made up ﹤0.01% of PGIM Custom Harvest's portfolio in Q1 2026, its #227 holding.
  • PGIM Custom Harvest first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • PGIM Custom Harvest's Merck position peaked at $509K in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PGIM Custom Harvest's 13F filing for Q1 2026, filed 13 May 2026.